The differences between CBPR and traditional research have been enumerated, but how to overcome them is still up for discussion, collaboration with community members is advocated, and examples are given.
PSOs are not required to share their data, which limits the ability to achieve a much-needed national perspective. Regardless, the are a step in the right direction.
Elizabeth Lee Daugherty, MD, MPH and Douglas B. White, MD, MA
Opportunities to advance scientific knowledge may arise during humanitarian crises, but their presence does not justify suspension of the ethical foundations governing human subjects research.
“Difficult” patient encounters can be exacerbated by procedural and technological infrastructure that increases access to electronic health records (EHRs).
AMA J Ethics. 2017;19(4):374-380. doi:
10.1001/journalofethics.2017.19.4.stas1-1704.
Does a surgeon’s complication rate in a randomized controlled trial constitute a “significant new finding” that must be reported to patients during the consent process?
Dr Majd Alsoubani joins Ethics Talk to discuss her article, coauthored with Drs Maya Nadimpalli and Shira Doron: "How Should Health Care Respond to Threats Antimicrobial Resistance Poses to Workers?”
Lloyd Duplechan joins Ethics Talk to discuss health organizations’ responsibilities to protect employees and community members from antimicrobial resistance.
Antibiotics can be compared to other forms of “tragedy of the commons,” whereby a common good (effective treatment of infections) is jeopardized by individual consumption and lack of stewardship.
AMA J Ethics. 2024;26(5):E418-428. doi:
10.1001/amajethics.2024.418.